Resolving Tuberculosis Transmission Using Long Read And Deep Sequencing Data To Inform Targeted Interventions

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

May 31, 2030
Response Due
Active
Status

Opportunity Overview

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a major global health concern, causing around 1.3 million deaths in 2022. The World Health Organization's 'End TB Strategy' sets out to reduce TB deaths significantly by 2035 and ultimately eliminate the disease worldwide. Unfortunately, many countries are falling behind global targets for elimination, with efforts also hampered in recent years due to disruptions in diagnosis and treatment during the COVID-19 pandemic. A central pillar of the 'End TB Strategy' is to identify high-risk groups and individuals to ensure early diagnosis of the disease to direct targeted, cost-effective treatment strategies and prioritise contacts for preventative therapy.
We can understand factors that contribute to the spread of pathogens to guide control efforts by reconstructing the transmission history of past outbreaks using whole genome sequence (WGS) data. By linking cases with few genomic differences, likely chains of transmission and highly transmissible infections can be identified. WGS can also be used to detect complex disease states such as mixed infection. However, this is not a trivial exercise in clonal organisms like TB where low population-level diversity leads to many seemingly identical sequences, confounding efforts to identify who-infected-whom or fully characterise within-host variation.
Long-read, deep sequencing can improve whole genome assemblies by accurately reconstructing genomic features that are routinely ignored in Mtb, such as highly variable genes linked to virulence (PE/PPE genes), repetitive elements, and insertions and deletions. It can be difficult to assemble these features with short-read sequence data as reads are far shorter in length than the target gene. In contrast, long-read sequencing produces reads that span the length of multiple genes to allow for high confidence sequence reconstruction in these complex regions. Previously under-characterised regions comprise almost...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedMay 31, 2025
Procurement stageActive solicitation
Response dueMay 31, 2030
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.